{"changes":[],"country":"US","description":"MapLight Therapeutics develops small-molecule treatments for neuropsychiatric and neurological conditions including autism-related social symptoms and schizophrenia. Patients with serious psychiatric disorders are the eventual customer base. MapLight pursues circuit-targeted mechanisms in partnership with academic neuroscience labs.","domain":"maplighttx.com","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":37.385391,"lng":-122.033657,"location":"Redwood City, CA","name":"MapLight Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":372500000,"currency":"USD","date":"2025-07-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"maplighttx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},{"fact":"existence","publisher":"maplighttx.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplighttx.com"},{"fact":"description","publisher":"maplighttx.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplighttx.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":400000000,"updatedAt":"2026-05-26"}